![](/img/cover-not-exists.png)
Once-Daily Lixisenatide in Combination with Basal Insulin ± Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes Selectively Reduces Postprandial Hyperglycemic Daytime Exposure
Bajaj, Harpreet S., Gomez-Huelgas, Ricardo, Riddle, Matthew C., Seino, Yutaka, Cariou, Bertrand, Roy-Duval, Christine, Hecquet, Carole A., Digenio, Andres, Rosenstock, JulioVolume:
37
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2013.08.090
Date:
October, 2013
File:
PDF, 135 KB
english, 2013